Bilberry Extract

Chemco Technology Limited supplies a bilberry extract standardised to 25 percent anthocyanins by content, derived from Vaccinium myrtillus fruit sourced in China. The extract is marketed under the Chemcohealth brand line and is positioned for dietary supplement and functional food applications, particularly those targeting ocular health and antioxidant support. The 25 percent standardisation refers to the total anthocyanin content expressed as cyanidin-3-glucoside equivalents, a common analytical convention in the botanical extract industry. This concentration level permits predictable dosing in finished formulations and is consistent with grades used in clinical research on visual function and vascular integrity.

The raw material is Chinese-sourced bilberry, distinct from the closely related blueberry (Vaccinium corymbosum) though often conflated in commercial terminology. Standard bilberry extracts at 25 percent anthocyanin content typically contain a spectrum of anthocyanin glycosides including cyanidin-3-galactoside, cyanidin-3-glucoside, delphinidin-3-galactoside, delphinidin-3-glucoside, petunidin-3-glucoside, and malvidin-3-glucoside, with the galactosides predominating in Vaccinium myrtillus. Carrier materials such as maltodextrin may be present depending on the extraction and drying process employed. The extraction solvent system, whether aqueous, ethanolic, or a combination, affects residual solvent profiles and regulatory compliance status.

Primary buyers include dietary supplement manufacturers, functional beverage formulators, and cosmetic companies developing antioxidant topical products. The extract finds use in capsules, tablets, softgels, and powder drink premixes. Trade terms referenced in the source include FOB and CIF shipping options, with payment terms of letter of credit and telegraphic transfer, though specific pricing, MOQ, and lead time figures are not provided and must be negotiated directly with Chemco Technology Limited. The supplier carries a harbor trust tier with no recorded response history, so initial engagement should assess communication reliability and technical competence.

Chemco Technology Limited is a China-based supplier trading under the Chemcohealth brand for herbal extract products. The company holds a harbor trust tier and imported supplier classification, which indicates the listing originates from a platform-verified source rather than direct factory representation. No physical address, factory location, or registration details are provided in the source material. The response rate is recorded at 0.00 percent with no average response time data, so prospective buyers cannot rely on historical communication performance metrics.

The source description contains no information about establishment year, production facility scale, number of employees, annual turnover, specific manufacturing certifications, or named customers. Claims of being a 'leader in herbal extract manufacturing' appear in the source but lack independent verification or supporting documentation. Buyers should request proof of manufacturing capability, quality management system certification (such as ISO 9001, ISO 22000, or HACCP), and specific GMP compliance status. Due diligence is particularly important given that the source text contains platform self-referencingman's intervention: